Immediate Impact
2 from Science/Nature 60 standout
Citing Papers
BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells
2025 Standout
Natural killer cell therapies
2024 StandoutNature
Works of Joerg Thomas Bittenbring being referenced
Daratumumab for a Patient With Refractory Antineutrophil Cytoplasmatic Antibody–Associated Vasculitis
2023
The impact of Fc-γ receptor polymorphisms in elderly patients with diffuse large B-cell lymphoma treated with CHOP with or without rituximab
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Joerg Thomas Bittenbring | 346 | 290 | 114 | 145 | 55 | 787 | |
| B. Johansson | 329 | 214 | 157 | 66 | 42 | 980 | |
| Berksoy Şahin | 175 | 316 | 55 | 158 | 57 | 807 | |
| Walter Longo | 248 | 381 | 114 | 114 | 62 | 819 | |
| Luciano Moretti | 312 | 300 | 94 | 83 | 38 | 891 | |
| Masaru Nakano | 172 | 157 | 75 | 172 | 81 | 898 | |
| Itai Levi | 203 | 193 | 83 | 141 | 58 | 804 | |
| Lei Zhang | 152 | 214 | 113 | 102 | 76 | 726 | |
| Gilles Lugassy | 217 | 167 | 189 | 117 | 55 | 765 | |
| J. A. McBride | 236 | 166 | 104 | 135 | 33 | 872 | |
| Ziad Salem | 104 | 230 | 58 | 137 | 39 | 691 |
All Works
Login with ORCID to disown or claim papers
Loading papers...